MBIRA - Mortality from Bacterial Infections Resistant to Antibiotics study - underlying data

Antimicrobial resistance is a major global health concern, but there is limited data linking laboratory resistance testing to clinical outcomes, especially from Low-and-Middle-Income countries, including African nations. This is a project collecting prospective data about bloodstream infections caused by Enterobacterales bacteria in African hospitals in 2020-22. A central focus was the impact of 3rd generation cephalosporin (3GC) resistance on patient mortality. In the main study, n=8 hospitals in eight different countries contributed to this project. Preliminary work involved collection of descriptive information from these 8 hospitals, including access to antibiotics in hospital pharmacies. Information was collected for infected patients and matched non-infected patients in same hospitals. The MBIRA study collected data about hospitals, patients, bacterial isolates and antibiotic use. The “mbira_hospital” dataset contains information collected as a one-off event as part of the “hospital” form and the “mbira_pharmacy” contains information on antibiotic availability in pharmacies that were collected each month. Further datasets will be made available at a later date.

Additional Information

Version 1 of the ‘mbira_pharmacy_data’ dataset was available between Jan 9 - 23, 2023. This was replaced with 'mbira_pharmacy_v2' on Jan 23 2023, which contains an additional table containing collapsed data for scatter plot.

Keywords

Antimicrobial resistance, clinical outcomes, Enterobacterales, Bacteria, LMIC